Schedule 13G ownership disclosure
AQUINOX PHARMACEUTICALS, INC
Security class unavailable · CUSIP: 03842B101
Event date: 2014-03-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,211,851
- Percent of class
- 12.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-14-021862
- Form type
- SC 13G
- Filer
- Neurogene Inc.
- CIK
- CIK 1404644
- Filed
- Apr 10, 2014
- Reporting period
- Mar 07, 2014
- Description
- Schedule 13G beneficial ownership